Mutated VHL, as often observed in ccRCC, leads to stabilization of HIF-1/2α that activates target genes underlying ccRCC-associated alterations in tumor metabolism, genome-wide epigenetic changes, tumor growth and metastasis [5,8,9,10]. The gene discussed is VHL; the disease is neoplasm.